Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Ophthalmology. 2010 Apr 28;117(6):1064–1077.e35. doi: 10.1016/j.ophtha.2010.02.031

Table 14.

Diabetic Retinopathy Progression from Baseline to 1 Year by Baseline Retinopathy Severity Group

Change from Baseline to 1-Year Visit* Sham N = 233 Ranibizumab N = 303 Triamcinolone N = 150
Baseline severity: Moderately severe NPDR or better, No. (%) N = 150 N = 182 N = 80
Improved by 2 or more levels 6 (4%) 46 (25%) 20 (25%)
Worsened by 2 or more levels 11 (7%) 5 (3%) 2 (3%)
P value for comparison with Sham P = 0.08 P = 0.17
Baseline severity: Severe NPDR or worse, No. (%) N = 83 N = 121 N = 70
Improved by 2 or more levels 10 (19%) 18 (28%) 6 (13%)
Worsened by 2 or more levels 7 (8%) 1 (1%) 2 (3%)
P value for comparison with Sham P = 0.03 P = 0.17

NPDR = non-proliferative diabetic retinopathy

*

N = 685; 113 eyes had missing or ungradeable photos at 1 year

Excludes 127 eyes with baseline Level 60 (scars of full or partial PRP present; abnormalities of PDR absent)